253 related articles for article (PubMed ID: 17449487)
1. Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept.
Kuek A; Weerakoon A; Ahmed K; Ostör AJ
Rheumatology (Oxford); 2007 Jun; 46(6):1043-4. PubMed ID: 17449487
[No Abstract] [Full Text] [Related]
2. Comment on: Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept.
Binymin KA
Rheumatology (Oxford); 2007 Nov; 46(11):1741-2 author reply 1742-3. PubMed ID: 17956919
[No Abstract] [Full Text] [Related]
3. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.
Fautrel B; Sibilia J; Mariette X; Combe B;
Ann Rheum Dis; 2005 Feb; 64(2):262-6. PubMed ID: 15184196
[TBL] [Abstract][Full Text] [Related]
4. Etanercept in the treatment of adult patients with Still's disease.
Husni ME; Maier AL; Mease PJ; Overman SS; Fraser P; Gravallese EM; Weinblatt ME
Arthritis Rheum; 2002 May; 46(5):1171-6. PubMed ID: 12115220
[TBL] [Abstract][Full Text] [Related]
5. Exacerbation of adult-onset Still's disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration.
Kaneko K; Kaburaki M; Muraoka S; Tanaka N; Yamamoto T; Kusunoki Y; Abe H; Endo H; Kawai S
Int J Rheum Dis; 2010 Oct; 13(4):e67-9. PubMed ID: 21199457
[TBL] [Abstract][Full Text] [Related]
6. Prolonged remission in adult-onset Still's disease with etanercept.
Kumari R; Uppal SS
Clin Rheumatol; 2006 Feb; 25(1):106-8. PubMed ID: 15856368
[No Abstract] [Full Text] [Related]
7. Potential role of macrophage migration inhibitory factor in adult-onset Still's disease.
Becker H; Gaubitz M; Domschke W; Willeke P
Scand J Rheumatol; 2009; 38(1):69-71. PubMed ID: 18686192
[No Abstract] [Full Text] [Related]
8. [Application of etanercept in treatment of juvenile idiopathic arthritis and adult onset still disease].
Lewicki M; Kotulska A; Kucharz EJ
Pol Arch Med Wewn; 2005 May; 113(5):505-8. PubMed ID: 16479836
[No Abstract] [Full Text] [Related]
9. Etanercept allergy and anaphylaxis.
Quismorio A; Brahmbhatt B; Houng M; Panush RS
J Rheumatol; 2012 Nov; 39(11):2225-6. PubMed ID: 23118296
[No Abstract] [Full Text] [Related]
10. [Adult-onset Still's disease with pulmonary and cardiac involvement and response to intravenous immunoglobulin].
Neto NS; Waldrich L; de Carvalho JF; Pereira RM
Acta Reumatol Port; 2009; 34(4):628-32. PubMed ID: 20087268
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin in the treatment of refractory adult Still's disease.
Mahmud T; Hughes GR
J Rheumatol; 1999 Sep; 26(9):2067-8. PubMed ID: 10493699
[No Abstract] [Full Text] [Related]
12. Steroid-sparing effects of etanercept in a patient with steroid-dependent adult-onset Still's disease.
Kiyonaga Y; Maeshima K; Imada C; Haranaka M; Ishii K; Shibata H
Intern Med; 2014; 53(11):1209-13. PubMed ID: 24881751
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulins in Still's disease: still controversial, still unproven.
Prieur AM
J Rheumatol; 1996 May; 23(5):797-800. PubMed ID: 8724286
[No Abstract] [Full Text] [Related]
14. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
Efthimiou P; Kontzias A; Ward CM; Ogden NS
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):328-35. PubMed ID: 17538564
[TBL] [Abstract][Full Text] [Related]
15. Adult onset Still's disease: response to Enbrel.
Asherson RA; Pascoe L
Ann Rheum Dis; 2002 Sep; 61(9):859-60; author reply 860. PubMed ID: 12176823
[No Abstract] [Full Text] [Related]
16. Cardiac magnetic resonance in myocarditis from adult onset Still's disease successfully treated with anakinra.
Choi AD; Moles V; Fuisz A; Weissman G
Int J Cardiol; 2014; 172(1):e225-7. PubMed ID: 24461482
[No Abstract] [Full Text] [Related]
17. Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept.
Maeshima K; Ishii K; Iwakura M; Akamine M; Hamasaki H; Abe I; Haranaka M; Tatsukawa H; Yoshimatsu H
Mod Rheumatol; 2012 Feb; 22(1):137-41. PubMed ID: 21670967
[TBL] [Abstract][Full Text] [Related]
18. [Longterm outcome of TNF blockade in adult-onset Still's disease].
Dechant C; Schauenberg P; Antoni CE; Kraetsch HG; Kalden JR; Manger B
Dtsch Med Wochenschr; 2004 Jun; 129(23):1308-12. PubMed ID: 15179590
[TBL] [Abstract][Full Text] [Related]
19. [Still's disease, adult-onset Still's disease (AOSD)].
Naumann UK; Nigg Ch; Käser L; Vetter W
Praxis (Bern 1994); 2006 Sep; 95(36):1353-60; quiz 1360. PubMed ID: 16989179
[No Abstract] [Full Text] [Related]
20. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
